RxDoctor Payments Data

Joseph Casaly

Neurology · Southlake, TXNPI 1750381125

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $76,413 of the $94,686 with a category attached, or 80.7%. 17 manufacturers reported payments, led by Lilly USA, LLC at 25.3% of the total. Reporting peaked in 2019 at $54,715 and has fallen 99.4% since, to $301 in 2022. Among neurology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$94,686in general payments, 2019–2025

Across 228 payments — averaging $415.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$24K
  • Amgen$23K
  • Teva Pharmaceuticals USA, Inc.$22K
  • AbbVie$20K
  • Promius Pharma LLC$5K
  • Biohaven Pharmaceutical Holding Company Ltd.$62
  • plus $288 from 11 others

What the payments were for

  • Consulting fees$9,17510%
  • Speaking & faculty fees$76,41381%
  • Travel & lodging$4,9665%
  • Food & beverage$4,0824%
  • Education$510%

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$94,686 in reported general payments places this provider in the 90th percentile of 1,246 neurology providers in Texas.

See all neurology providers in Texas →

Other neurology in Southlake

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →